Hints and tips:
...Ms Richo, who most recently served as general counsel of Belgian biopharma company UCB, will become a member of the executive team and succeeds Laura Witte, who retired in May....
...Newble Managing Director, TTPLabtech Mark Tucker Chief Executive, TTS Pharma Jayne Spink Chief Executive, Tuberous Sclerosis Association Dr Neil Weir Senior Vice-President of Discovery Research, UCB...
...GlaxoSmithKline and Baxter have long had significant R&D presences in Wallonia, surrounded by homegrown forces such as UCB, a biopharma company that focuses on diseases affecting the nervous and immune systems...
...Aesica Pharmaceuticals, a UK-based developer and manufacturer of active pharmaceutical ingredients, has agreed to acquire three manufacturing sites in Germany and Italy from UCB, the Belgian biopharma company...
...Celltech was purchased by Belgium’s UCB for £1.53bn ($3.03bn, €1.93bn)....
International Edition